10-15 Associates’s Bristol-Myers Squibb BMY Stock Holding History

10-15 Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2.45M	Buy	40,698 +3,440	+9%	+$207K	0.48%	51
2020 Q2	$2.19M	Buy	37,258 +529	+1%	+$31.6K	0.44%	49
2020 Q1	$2.05M	Buy	36,729 +2,610	+8%	+$160K	0.48%	47
2019 Q4	$2.19M	Buy	+34,119	New	+$1.95M	0.41%	56
2016 Q4	–	Sell	-4,157	Closed	-$224K	–	99
2016 Q3	$224K	Buy	+4,157	New	+$267K	0.06%	107
2016 Q2	–	Sell	-3,201	Closed	-$204K	–	115
2016 Q1	$204K	Sell	3,201 -430	-12%	-$27.1K	0.06%	101
2015 Q4	$250K	Buy	+3,631	New	+$240K	0.07%	102
2015 Q3	–	Sell	-3,451	Closed	-$229K	–	110
2015 Q2	$229K	Sell	3,451 -275	-7%	-$18.1K	0.07%	109
2015 Q1	$240K	Hold	3,726	–	–	0.08%	108
2014 Q4	$219K	Buy	+3,726	New	+$210K	0.07%	105

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

10-15 Associates's BMY Position: Q3 2020 in Review

10-15 Associates increased its Bristol-Myers Squibb (BMY) stake by 9.2% in Q3 2020, buying an estimated $207K and bringing the position to 40,698 shares worth $2.45M. The position accounts for 0.48% of the portfolio, ranked #51.

10-15 Associates first reported a position in BMY in Q4 2014 and has held it in 10 quarters since. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

10-15 Associates held 40,698 shares of Bristol-Myers Squibb worth $2.45M as of Q3 2020.
10-15 Associates bought 3,440 Bristol-Myers Squibb shares in Q3 2020, an estimated $207K.
Bristol-Myers Squibb made up 0.48% of 10-15 Associates's portfolio in Q3 2020, its #51 holding.
10-15 Associates first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 10 quarters since.
2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.